中文同义词:
2-[(3-三氟甲基)苯基]氨基-3-吡啶羧酸苯酞酯;他尼氟酯;氟烟酞酯;氟尼酸酯;酞尼氟酯
英文同义词:
2-(alpha,alpha,alpha-trifluoro-m-toluidino)-nicotinicaciphthalidylester;3-ftalidilicodelacido2-((3-(trifluormetil)fenil)amino)-3-piridincarboxilic;3-phthalidylesterof2-((3-(trifluoromethyl)phenyl)amino)-3-pyridinecarboxyl;Talniflumate, >=99%;2-(alpha,alpha,alpha-trifluoro-m-toluidino)nicotinicacidphthalidylester;2-[3-(trifluoromethyl)anilino]-3-pyridinecarboxylic acid (3-oxo-1H-isobenzofuran-1-yl) ester;(3-oxo-1H-2-benzofuran-1-yl) 2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylate;ba7602-06
相关类别:
生物活性小分子;他尼氟酯及中间体;医用原料
沸点
534.6±50.0 °C(Predicted)
密度
1.49±0.1 g/cm3(Predicted)
酸度系数(pKa)
2.72±0.10(Predicted)
最大波长(λmax)
287nm(CHCl3)(lit.)
生物活性
Talniflumate (MSI-1995)是一种抗炎药,在治疗囊胞性纤维症、慢性阻塞性肺病和哮喘中被用作粘蛋白调节剂。Talniflumate 也是一种人钙激活的氯离子通道chloride channels。
靶点
IC50: Ca 2+ -activated Cl - channel (CaCC)
体内研究
Talniflumate (oral chow; 0.4 mg/g; 21 days) significantly increases CF mouse survival from 26 to 77%. It does not alter crypt goblet cell numbers or change intestinal expression of mCLCA3 but tends to decrease crypt mucoid impaction.
Animal Model: CF mice with distal intestinal obstructive syndrome (DIOS)
Dosage: 0.4 mg/g
Administration: Oral chow; 21 days
Result: Increased survival in a cystic fibrosis mouse model of distal intestinal obstructive syndrome.
Animal Model:
CF mice with distal intestinal obstructive syndrome (DIOS)
Administration:
Oral chow; 21 days
Result:
Increased survival in a cystic fibrosis mouse model of distal intestinal obstructive syndrome.
用途
该品为非甾体消炎镇痛原料药,同时可用于纤维性囊肿和哮喘的辅助治疗。
用途
为非甾体消炎镇痛药,同时可用于纤维性囊肿和哮喘的辅助治疗
毒性
LD50 orally in rats: 12000 mg/kg (Los)